TEVA PHARMACEUTICAL INDUSTRIES LIMITED Current Income Tax Expense (Benefit)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Current Income Tax Expense (Benefit) of $1.09 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2025-02-05
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED current income tax expense (benefit) for fiscal 2024 was $1.09B, a 228.53% increase from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED current income tax expense (benefit) for fiscal 2023 was $333.00M, a 22.56% decline from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED current income tax expense (benefit) for fiscal 2022 was $430.00M, a 59.26% increase from fiscal 2021.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED current income tax expense (benefit) for fiscal 2021 was $270.00M, a 48.35% increase from fiscal 2020.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $1.09B 10-K · filed 2025-02-05 |
| 2023-12-31 | $333.00M 10-K · filed 2025-02-05 |
| 2022-12-31 | $430.00M 10-K · filed 2025-02-05 |
| 2021-12-31 | $270.00M 10-K · filed 2024-02-12 |
| 2020-12-31 | $182.00M 10-K · filed 2023-02-10 |
| 2019-12-31 | $885.00M 10-K · filed 2022-02-09 |
| 2018-12-31 | $700.00M 10-K · filed 2021-02-10 |
| 2017-12-31 | $373.00M 10-K · filed 2020-02-21 |
| 2016-12-31 | $481.00M 10-K · filed 2019-02-19 |
| 2015-12-31 | $298.00M 10-K · filed 2018-02-12 |
| 2014-12-31 | $879.00M 20-F · filed 2017-02-15 |
| 2013-12-31 | $1.10B 20-F · filed 2016-02-11 |
| 2012-12-31 | $564.00M 20-F · filed 2015-02-09 |
| 2011-12-31 | $689.00M 20-F · filed 2014-02-10 |
| 2010-12-31 | $560.00M 20-F · filed 2013-02-12 |
| 2009-12-31 | $408.00M 20-F · filed 2012-02-17 |
| 2008-12-31 | $490.00M 20-F · filed 2011-02-15 |